Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barrett

Showing results (1161-1170 of 1,348) with videos related to

Pageof 135
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical TrialStephan Kadauke, Regina M Myers, Yimei Li, et al.
Health Promotion International|November 5, 2021
Developing a health promoting university in Trinity College Dublin-overview and outline process evaluationCatherine D Darker, Martina Mullin, Louise Doyle, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Blood|December 5, 2021
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemiaChangya Chen, Wenbao Yu, Fatemeh Alikarami, et al.
Annals of Vascular Surgery|January 24, 2025
Higher Rate of Reinterventions after Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study Between 2015-2024Camila Esquetini-Vernon, James F Meschia, Josephine Huang, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago)R Ubillas, S D Jolad, R C Bruening, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 135

Showing results (1161-1170 of 1,348) with videos related to

Sort By:
Pageof 135
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical TrialStephan Kadauke, Regina M Myers, Yimei Li, et al.
Health Promotion International|November 5, 2021
Developing a health promoting university in Trinity College Dublin-overview and outline process evaluationCatherine D Darker, Martina Mullin, Louise Doyle, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Blood|December 5, 2021
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemiaChangya Chen, Wenbao Yu, Fatemeh Alikarami, et al.
Annals of Vascular Surgery|January 24, 2025
Higher Rate of Reinterventions after Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study Between 2015-2024Camila Esquetini-Vernon, James F Meschia, Josephine Huang, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago)R Ubillas, S D Jolad, R C Bruening, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 135